Latest Glenmark Pharmaceuticals Limited Stories

2014-06-04 08:29:36

MUMBAI and LA CHAUX-DE-FONDS, Switzerland, June 4, 2014 /PRNewswire/ -- - State-of-the-art Manufacturing Facility for Supply of Clinical Trial Material - With the Facility Glenmark has end-to-end Capabilities for the Development of Novel, State-of-the-art Monoclonal Antibodies Including Bi-specific Antibodies Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Limited, India (GPL), announced the opening of its new cGMP...

2011-05-16 09:32:00

MUMBAI, India, May 16, 2011 /PRNewswire-FirstCall/ -- Glenmark Pharmaceuticals S.A (GPSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL), announced today that it has entered into an agreement with Sanofi to grant Sanofi a license for the development and commercialization of GBR 500, a novel monoclonal antibody for the treatment of Crohn's Disease and other inflammatory conditions. The transaction is expected to close in the coming month subject to customary...

2010-05-03 12:00:00

WOODCLIFF LAKE, N.J., May 3 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that its generic division, Par Pharmaceutical, has entered into an exclusive licensing agreement with Glenmark Generics Limited and Glenmark Generics Inc., USA to market ezetimibe 10 mg tablets, the generic version of Merck & Co. Inc.'s Zetia, in the U.S. Zetia is a cholesterol modifying agent with annual U.S. sales of approximately $1.4 billion, according to IMS Health...

2009-07-23 05:14:00

MUMBAI, July 23 /PRNewswire-FirstCall/ -- - A Police Complaint has Been Lodged by Hospital Authorities Citing Fraudulent Activity by the Clinical Investigator Dr. A Bhattacharya Working at the GG Hospital and the MP Shah Medical College - Glenmark Not Only Acts as the Whistle-Blower but Also Discontinues its Clinical Study at the Mentioned Site After receiving approval from the Drug Controller General of India(DCGI) for a multi-centre Phase IIb clinical study for its lead...

2009-06-24 08:55:00

Release Highlights - Melogliptin continues to demonstrate potential to be the best-in-class in achieving glycemic control with low incidence of hypoglycemia and neutral effect on body weight - Global Phase III trials likely to start by end 2009 - IND approved by USFDA - Glenmark takes a step closer towards becoming the first Indian company to have a truly global innovative drug for the world In the recently completed 12 week Phase IIb clinical...

2008-12-22 06:30:00

MUMBAI, December 22 /PRNewswire-FirstCall/ -- - Potential First-in-Class Anti-Secretory Anti-Diarrheal Agent for Multiple Indications Including HIV-Associated Diarrhea - Glenmark has Crofelemer Rights for diarrhea Indications in 140 Countries; Molecule Currently in Phase 3 trials. ROW Sales Market Opportunity of US $ 80 Million for HIV-Associated Diarrhea - Crofelemer has Been Granted Fast Track Designation by US-FDA Glenmark Pharmaceuticals Limited today announced...

Word of the Day
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'